Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
2.190
-0.060 (-2.67%)
At close: Aug 21, 2025, 4:00 PM
2.170
-0.020 (-0.91%)
After-hours: Aug 21, 2025, 7:29 PM EDT

Climb Bio Stock Forecast

Stock Price Forecast

The 2 analysts that cover Climb Bio stock have a consensus rating of "Buy" and an average price target of $9.50, which forecasts a 333.79% increase in the stock price over the next year. The lowest target is $9.00 and the highest is $10.

Price Target: $9.50 (+333.79%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$9.00$9.50$10$10
Change+310.96%+333.79%+356.62%+356.62%

Analyst Ratings

The average analyst rating for Climb Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJun '25Jul '25Aug '25
Strong Buy000
Buy112
Hold000
Sell000
Strong Sell000
Total112

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Baird
Baird
Buy
Initiates
$9
BuyInitiates$9+310.96%Aug 15, 2025
Oppenheimer
Oppenheimer
Buy
Initiates
$10
BuyInitiates$10+356.62%Jun 6, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.92
from -1.53
EPS Next Year
-0.97
from -0.92
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
--------
Revenue Growth
--------
EPS
-10.49-4.24-1.72-1.30-1.53-0.92-0.97-1.09
EPS Growth
--------
Forward PE
--------
No. Analysts
-----444
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027
Highn/an/an/a
Avgn/an/an/a
Lown/an/an/a

Revenue Growth

Revenue Growth202520262027
High---
Avg---
Low---

EPS Forecast

EPS202520262027
High-0.93-0.98-1.01
Avg-0.92-0.97-1.09
Low-0.89-0.96-1.16

EPS Growth

EPS Growth202520262027
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.